November - 2018
| Previous Next | Showing Journal 7 of 9 |
Haloperidol and Ziprasidone for Treatment of Delirium in Critical IllnessTimothy D. Girard, M.D., M.S.C.I., Matthew C. Exline, M.D., M.P.H., Shannon S. Carson for the MIND-USA Investigators New Eng J Med, 2018, Online first This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
November |
Previous Comments
No Comments yet.
Comment
Delirium affects over half our ventilated patients, and is associated with longer length of stay, increased mortality, care issues such as device removal, and long term cognition. As our focus on this problem intensifies, so does our desire to understand the best pharmaceutical...